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Gated single-photon emission computed tomography
(SPECT) imaging allows analysis of myocardial perfusion
and assessment of baseline global and regional left
ventricular (LV) function and their changes during low-
dose dobutamine infusion. The study examined whether
the changes in LV ejection fraction induced by dobut-
amine and evaluated using technetium-99m sestamibi-
gated SPECT predict the evolution of ejection fraction
after revascularization in patients with ischemic cardio-
myopathy. Thirty-seven patients underwent resting and
dobutamine nitrate-enhanced sestamibi-gated SPECT
before revascularization and baseline-resting sestamibi
gated SPECT after intervention to assess global func-
tional changes. A postrevascularization improvement in
ejection fraction >5 U was defined as significant. At
follow-up, ejection fraction increased significantly in 19
patients. According to receiver-operating characteristic
curve analysis, an increase in ejection fraction>5 U during
dobutamine was the optimal cutoff value for predicting a
significant postrevascularization improvement, with 79%
sensitivity, 78% specificity, and 78% accuracy. A signifi-
cant correlation was found between dobutamine and pos-
trevascularization ejection fraction (r  0.85; p <0.0001).
The increase in ejection fraction during dobutamine is a
good predictor of an improvement in ejection fraction after
revascularization. This represents another important diag-
nostic contribution obtained using gated SPECT imaging
for the assessment of myocardial viability in patients
with ischemic cardiomyopathy. 2002 by Excerpta
Medica, Inc.
(Am J Cardiol 2002;89:817–821)
The acquisition of perfusion images using gatedsingle-photon emission computed tomography
(SPECT) allows the assessment of regional and global
left ventricular (LV) function.1 These additional data
are useful in detecting myocardial viability.2–4 More-
over, the acquisition of gated SPECT images during
low-dose dobutamine infusion permits assessment of
the regional contractile reserve of asynergic seg-
ments.5–8 On the other hand, using gated SPECT, LV
volumes and ejection fraction can be estimated in a
reliable and reproducible way.1 Thus, this study ex-
amines whether the changes in LV ejection fraction
during dobutamine stimulation, evaluated using tech-
netium-99m sestamibi-gated SPECT, predict changes
in ejection fraction after revascularization in patients
with ischemic cardiomyopathy.
METHODS
Patient group: We prospectively evaluated 63 con-
secutive patients (57 men, mean age 65  9) with
coronary artery disease and impaired LV function
(mean LV ejection fraction 32  9%, range 9% to
49%) referred to our laboratory for viability assess-
ment using dobutamine nitrate-enhanced gated sesta-
mibi SPECT. Patients with recent (1 month) myo-
cardial infarction or unstable angina, heart disease
other than coronary artery disease, atrial fibrillation, or
history of sustained ventricular tachycardia were ex-
cluded. Of this group, 37 patients (33 men, mean age
63  9) who underwent complete myocardial revas-
cularization (14 with coronary artery bypass grafting
and 23 with coronary angioplasty) within 1 month of
the scintigraphic analysis were included in this study.
The decision for revascularization was based on the
independent judgment of the referring physician. All
patients but 2 had a history of previous myocardial
infarction.
Study protocol: All patients underwent in a single
session resting and dobutamine nitrate-enhanced ses-
tamibi-gated SPECT. Baseline resting sestamibi-gated
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SPECT was repeated after revascularization (3
months for bypass grafting and 1 month for coronary
angioplasty) to assess global functional outcome and
myocardial perfusion. Studies were performed after
overnight fasting. Nitrates and -adrenergic blocking
agents were withdrawn 48 hours before the tests. All
patients gave informed consent to participate in the
study, which was approved by the ethics committee of
our institution.
Sestamibi-gated SPECT: The method of nitrate-en-
hanced sestamibi imaging has been described.9,10 One
hour after sestamibi (1,111 MBq, 30 mCi) injection,
baseline resting gated SPECT was performed. Imme-
diately thereafter, the dobutamine study was per-
formed. Infusion was started at a dose of 5 g/kg body
weight/min and increased after 5 minutes to 10 g/
kg/min. Criteria for early interruption included hypo-
tension, angina, or significant ventricular arrhythmia.
Gated SPECT acquisition was started after 3 minutes
of the 10-g dose, which was maintained until acqui-
sition was completed. For the postrevascularization
study, the same dose of sestamibi was injected at rest,
followed 1 hour later by SPECT acquisition. A dual-
head gamma camera (ADAC Vertex, Milpitas, Cali-
fornia) equipped with high-resolution collimators and
with a 15% window centered on the 140-keV photo-
peak of technetium-99m was used for image collec-
tion. SPECT was performed in step-and-shoot mode,
with 32 projections over a 180° elliptical orbit, matrix
size 64  64, 45 seconds/projection, 8 frames/cardiac
cycle. The studies were reconstructed using filtered
back-projection without attenuation or scatter correc-
tion and realigned along the heart axis. For perfusion
and functional analysis, the left ventricle was divided
into 16 segments and 3 coronary territories were con-
sidered.7,8 Tracer uptake was quantified with an auto-
matic program that calculated the mean uptake of each
segment, identified the segment with peak uptake, set
it to 100% activity, and scaled the other segments as a
percentage of peak activity.10 Regional function was
assessed visually by consensus of 2 experienced ob-
servers and scored using a 4-point scale (1  normal;
2  hypokinesia; 3  akinesia; 4  dyskinesia).7,8,11
The reproducibility of regional functional scoring in
our laboratory has been reported.7 The assessment of
viability was restricted to the revascularized segments
with abnormal function at rest (score 2 to 4). Two
criteria for detecting viability were considered: ni-
trate-sestamibi activity 50% in perfusion study,12
and contractile reserve on dobutamine-gated SPECT
study (defined by a decrease of 1 grade in regional
wall motion score during dobutamine administra-
tion).7,8 Data processing and calculation of LV end-
diastolic and end-systolic volumes and LV ejection
fraction were performed by an automated and vali-
dated method.13 Significant improvement in global
LV ejection fraction after revascularization was de-
fined as an increase of5 ejection fraction units in the
follow-up control compared with the baseline val-
ue.14,15
Statistical analysis: Results are expressed as mean
 SD. The comparison of variables within and be-
tween groups was performed with the Student’s t test
for paired or independent samples as appropriate. The
comparison of proportions was made using the Fish-
er’s exact test. The correlation between LV volumes
and LV ejection fraction during dobutamine and after
revascularization was calculated using Pearson’s cor-
relation coefficient. The sensitivity and the specificity
of dobutamine sestamibi-gated SPECT to predict an
increase in LV ejection fraction after revascularization
were calculated using receiver-operating characteris-
tics curve analysis. A p value 0.05 was considered
statistically significant.
RESULTS
Gated SPECT after revascularization versus baseline
gated SPECT: On follow-up gated SPECT, none of the
patients had worsening of perfusion in the coronary
territories submitted to revascularization. In the whole
study cohort, mean LV ejection fraction improved
from 34  10% before to 39  11% after revascular-
ization (p 0.001). According to the changes in ejec-
tion fraction, patients were divided into 2 groups:
group A (19 patients) had improvement in LV ejection
fraction 5 U after revascularization; group B (18
patients) did not have an increase in LV ejection
fraction 5 U after revascularization. No significant
differences in the 2 groups were observed regarding
demographic, clinical, and instrumental variables (Ta-
ble 1). Compared with baseline values, group A had a
reduction in end-diastolic (p 0.05) and end-systolic
(p 0.002) volumes so that after revascularization
these values were significantly lower than those ob-
served in group B (Table 1). The mean number of
viable asynergic segments was higher in group A than
in group B (Table 2). With use of a threshold of 4
viable segments to identify patients with LV ejection
fraction increase 5 U,15 sestamibi activity achieved
89% sensitivity, 67% specificity, and 78% accuracy.
Dobutamine-gated SPECT: During dobutamine there
was a marked variation (from –3 to 19 ejection
fraction units) of the LV ejection fraction with respect
to baseline values. Mean dobutamine ejection fraction
was 40  12% in group A (p 0.001 vs baseline) and
35  13% in group B (p 0.05 vs baseline). Accord-
ing to receiver-operating characteristics curve analy-
sis, the increase in LV ejection fraction 5 U during
dobutamine was the optimal cutoff value for predict-
ing a significant postrevascularization increase. An
improvement in ejection fraction 5 U during dobut-
amine was observed in 15 group A patients and in 4
group B patients (p0.005). The dobutamine increase
in LV ejection fraction 5 U predicted a significant
increase in ejection fraction after revascularization,
with a sensitivity, specificity, and overall accuracy of
79%, 78%, and 78%, respectively. The individual
changes in LV ejection fraction at baseline, during
dobutamine, and after revascularization are seen in
Figure 1. A significant correlation was found between
dobutamine LV ejection fraction and postrevascular-
ization ejection fraction (r 0.85; p0.0001) (Figure
2). Moreover, there was a significant correlation be-
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tween dobutamine end-diastolic (r  0.86; p
0.0001) and end-systolic (r  0.89; p 0.0001)
volumes and the related values after revascularization.
DISCUSSION
An important advantage of gated SPECT perfu-
sion imaging over other methods is the possibility
of obtaining data about myocardial perfusion and
regional and global function during the same acqui-
sition. The simultaneous assessment of perfusion
and regional function improves the accuracy of
simple perfusion study for the detection of myocar-
dial viability.2– 4 Gated SPECT imaging may also
provide evaluation of wall motion and thickening
changes during inotropic stimulation.5– 8 A good
agreement between gated SPECT and other imaging
techniques in evaluating contractile reserve elicited
by dobutamine infusion was demonstrated.5,7 In
detecting hibernating viable myocardium, the as-
sessment of contractile reserve adds diagnostic
power to perfusion imaging, and the combination of
perfusion and functional data significantly im-
proved the accuracy of sestamibi-
gated SPECT for predicting re-
gional reversible dysfunction.8
However, the most important clin-
ical goal of coronary revasculariza-
tion is improvement in global LV
function.16 Global functional im-
provement after revascularization
was correlated with the extent of
viable myocardium, defined by the
number of the asynergic segments
with preserved cellular membrane
integrity,17 maintained metabo-
lism,18 or contractile reserve.17,18
Also, according to our results, the
group of patients with improved
LV ejection fraction of 5 U after
revascularization had significantly
more revascularized viable asyner-
gic segments with preserved cellu-
lar membrane integrity or contrac-
tile reserve than patients without
significant LV ejection fraction im-
provement. Gated SPECT also al-
lows automated calculation of LV
volumes and ejection fraction, which can be esti-
mated in a reliable and reproducible way.1 The
results of this study suggest that dobutamine ejec-
tion fraction changes predict global functional re-
sponse after revascularization. A global increase of
at least 5 U in LV ejection fraction in response to
dobutamine is a good predictor of a significant
increase in LV ejection fraction after intervention.
The relation between dobutamine-induced and pos-
trevascularization ejection fraction changes con-
firms and expands the results of previous studies
performed using more established imaging tech-
niques.18–20 Zafrir et al20 found that dobutamine ra-
dionuclide ventriculography had a sensitivity of 67%
and specificity of 93% for predicting improvement in
global LV function after revascularization. In the
study of Sanchis et al,19 dobutamine contrast ventricu-
lography predicted an increase in LV ejection fraction
after revascularization with sensitivity and specificity
of 80% and 83%, respectively. Using dobutamine
echocardiography, Pasquet et al18 obtained a sensitiv-
ity of 93% and specificity of 90% for the prediction of
ejection fraction outcome. The increase in LV ejection
fraction during dobutamine echocardiography was a
stronger predictor of overall improvement in post-
revascularization ejection fraction than either the
number of viable asynergic segments identified by
maintained metabolism or preserved contractile re-
serve.18 In our study, dobutamine LV ejection fraction
showed a good diagnostic accuracy (79% sensitivity
and 78% specificity) for significant global function
improvement after revascularization. These results
confirm that dobutamine-induced ejection fraction
changes provide important diagnostic information for
assessing myocardial viability in patients with isch-
emic cardiomyopathy. This information can be easily
achieved using gated SPECT together with quantifi-
TABLE 1 Comparison of Clinical, Angiographic, and Scintigraphic Characteristics
Between Patients With (group A) and Without (group B) Improvement of 5 U in
LV Ejection Fraction After Revascularization
Variable
Group A
(n  19)
Group B
(n  18) p Value
Mean age (yrs) 64  9 63  10
Previous myocardial infarction
Anterior 12 14
Inferior 5 4
No. of narrowed coronary arteries
1 7 9
2–3 12 9
Mode of revascularization
Coronary angioplasty 10 13
Coronary bypass 9 5
Ejection fraction (%)
Baseline 34  9 33  12
Postrevascularization 44  8* 32  11 0.001
End-diastolic volume (ml)
Baseline 168  69 201  66
Postrevascularization 149  52† 195  62 0.01
End-systolic volume (ml)
Baseline 116  68 141  68
Postrevascularization 86  45‡ 135  99 0.01
*p 0.00001 versus baseline; †p  0.03 versus baseline; ‡p  0.001 versus baseline.
TABLE 2 Comparison of Revascularized Asynergic Segments
Classified as Viable According to Sestamibi Activity and
Contractile Reserve in Patients With (group A) Versus Without
(group B) Improvement of 5 U in LV Ejection Fraction After
Revascularization
Group A Group B
Sestamibi activity 50%
All asynergic segments 7  2.9 4  3*
Adyskinetic segments 3  1.7 2  1.6†
Contractile reserve
All asynergic segments 3.9  2.6 2  1.7†
*p  0.002; †p 0.005.
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cation of regional perfusion and evaluation of regional
contractile reserve.
The results of the present study must be evaluated
cautiously because of several limitations. A general
limitation of gated SPECT is that it cannot be used in
patients with atrial fibrillation or frequent ectopic
beats. As in many other studies using postrevascular-
ization global functional recovery as the reference
standard to define myocardial viability, the patient
group is quite small. Angiography was not performed
at follow up; thus, silent restenosis or graft occlusion
could not be completely ruled out, although resting per-
fusion was maintained or improved. However, recurrent
ischemia was excluded by clinical observation and neg-
ative exercise stress testing whenever necessary.
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